Skip to main content

Table 1 VEGF-R mRNA expression in leukemia and lymphoma cell lines

From: DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4)

   

KDR

   
 

+++

++

+

(+)

-

∑

AML

0

2

0

3

16

21

pre-B ALL

0

0

0

1

10

11

T-ALL

0

0

0

2

9

11

NK

0

0

0

0

5

5

CML

1

0

0

1

12

14

HL

0

0

0

0

5

5

ALCL

0

0

0

0

5

5

BL

0

0

0

0

5

5

DLBCL

0

0

0

0

5

5

FL

0

0

0

0

5

5

MCL

0

0

0

0

5

5

∑

1

2

0

7

82

92

   

FLT4

   
 

+++

++

+

(+)

-

∑

AML

0

2

4

3

14

23

pre-B ALL

0

3

1

3

4

11

T-ALL

0

0

2

4

5

11

NK

0

0

0

0

5

5

CML

0

1

1

3

10

15

HL

0

0

0

1

4

5

ALCL

0

0

0

0

5

5

BL

0

0

0

0

5

5

DLBCL

0

0

0

0

5

5

FL

0

0

0

0

5

5

MCL

0

0

0

0

5

5

∑

0

6

8

14

67

95

  1. KDR and FLT4 mRNA expression levels were determined by quantitative real-time PCR. TBP expression was used as endogenous control and cell lines CMK (KDR) and HEL (FLT4) were used for normalization. Relative quantification: +++ ≥ 5; ++ ≥ 1; + ≥ 0.2; (+) ≥ 0.04;- < 0.04. AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; NK, natural killer leukemia; CML, chronic myeloid leukemia; HL, Hodgkin lymphoma; ALCL, anaplastic large cell lymphoma; BL, Burkitt lymphoma; DLBCL, diffuse large B cell lymphoma; FL, follicular lymphoma, MCL, mantle cell lymphoma